Knight Therapeutics Inc (GUD) Common Stock NPV

Sell:9.68 CADBuy:9.89 CADPrice increased0.18 CAD (1.86%)

Market closed |
Prices delayed by at least 15 minutes
Sell:9.68 CAD
Buy:9.89 CAD
Change:Price increased0.18 CAD (1.86%)
Market closed |
Prices delayed by at least 15 minutes
Sell:9.68 CAD
Buy:9.89 CAD
Change:Price increased0.18 CAD (1.86%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
15 June 2026
Jonathan Ross GoodmanExecutive Chairman
Buy
Regular purchase transaction
2675.22 CAD1,393.74 CAD1,035,524
15 June 2026
Jonathan Ross GoodmanExecutive Chairman
Buy
Regular purchase transaction
7189.36 CAD6,720.48 CAD1,035,257
15 June 2026
Samira SakhiaPresident/CEO
Buy
Regular purchase transaction
7205.22 CAD3,758.40 CAD448,853
15 June 2026
Samira SakhiaPresident/CEO
Buy
Regular purchase transaction
1,9349.36 CAD18,102.24 CAD448,133
15 June 2026
Amal KhouriVice President
Buy
Regular purchase transaction
5935.22 CAD3,095.46 CAD200,177
15 June 2026
Amal KhouriVice President
Buy
Regular purchase transaction
7749.36 CAD7,244.64 CAD199,584
15 June 2026
Utchanah ArvindCFO
Buy
Regular purchase transaction
2965.22 CAD1,545.12 CAD109,663
15 June 2026
Utchanah ArvindCFO
Buy
Regular purchase transaction
6959.36 CAD6,505.20 CAD109,367
15 June 2026
Susan Caroline EmblemVice President
Buy
Regular purchase transaction
3615.22 CAD1,884.42 CAD45,597
15 June 2026
Susan Caroline EmblemVice President
Buy
Regular purchase transaction
8769.36 CAD8,199.36 CAD45,236

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 June 2026
Melanie GroleauVice President
Sell
Option/Award related
29,4039.25 CAD271,977.75 CAD10,391
13 April 2026
James C (Jim) GaleChairman of the Board
Sell
Option/Award related
24,4097.57 CAD184,750.00 CAD52,997
14 May 2026
Robert Nathaniel LandeIndependent Director
Sell
Regular sell transaction (market)
20,0008.40 CAD168,000.00 CAD203,178
14 May 2026
Robert Nathaniel LandeIndependent Director
Sell
Regular sell transaction (market)
20,0008.39 CAD167,800.00 CAD223,178
6 April 2026
Robert Nathaniel LandeIndependent Director
Sell
Option/Award related
20,0007.65 CAD153,000.00 CAD243,178

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.